IP Library Granted Patent US 7,368,554
Granted Patent B2
US 7,368,554 · App. 11/346,468 · Granted May 6, 2008

Polynucleotides encoding BSL2v1c2-Ig

Assignee: Bristol-Myers Squibb Company
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,368,554
App. No.
11/346,468
Granted
May 6, 2008
Kind
B2
Abstract

The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.

Claims (16)

1. An isolated polynucleotide sequence comprising a nucleic acid selected from the group consisting of:

(a) an isolated polynucleotide sequence comprising a polynucleotide encoding the amino acids 1 to 480 of SEQ ID NO:133;

(b) an isolated polynucleotide sequence comprising a polynucleotide encoding the amino acids 2 to 480 of SEQ ID NO:133; and

(c) an isolated polynucleotide sequence comprising a polynucleotide encoding the amino acids 29 to 480 of SEQ ID NO:133.

2. The isolated polynucleotide sequence of claim 1 , wherein said polynucleotide is (a).

3. The isolated polynucleotide sequence of claim 2 , wherein said polynucleotide comprises nucleotides 1 to 1440 of SEQ ID NO:132.

4. The isolated polynucleotide of claim 1 , wherein said polynucleotide is (b).

5. The isolated polynucleotide sequence of claim 4 , wherein said polynucleotide comprises nucleotides 4 to 1440 of SEQ ID NO:132.

6. The isolated polynucleotide of claim 1 , wherein said polynucleotide is (c).

7. The isolated polynucleotide sequence of claim 6 , wherein said polynucleotide comprises nucleotides 85 to 1440 of SEQ ID NO:132.

8. An isolated polynucleotide sequence comprising the cDNA clone contained in plasmid BSL2v1c2Ig in ATCC Deposit No. PTA-4056.

9. An isolated recombinant vector comprising the isolated nucleic acid molecule of claim 1 .

10. An isolated recombinant host cell comprising the vector of claim 9 .

11. A method of making an isolated polypeptide comprising:

(a) culturing the recombinant host cell of claim 10 under conditions such that said polypeptide is expressed; and

(b) recovering said polypeptide.

Continuity (5)
Division 1007702300 · Feb 15, 2002
Continuation In Part 0987533800 · Jun 6, 2001
Provisional Application 6027210700 · Feb 28, 2001
Provisional Application 6020981100 · Jun 6, 2000
Related Publication 20060159685A1 · Jul 20, 2006